Diagnostic evaluation for infertility in women should be conducted in a systematic,
expeditious, and cost-effective manner to identify all the relevant factors with an initial …

STUDY QUESTION Is serum anti-Müllerian hormone (AMH) level predictive of cumulative
live birth (CLB) rate after ART or in women trying to conceive naturally? SUMMARY …

Background Healthy individuals and patients with cancer who are carriers of germline
pathogenic variants in the BRCA1/2 genes face multiple reproductive challenges that …

BACKGROUND Anti-Müllerian hormone (AMH) serum concentration and antral follicle count
(AFC), as measured by transvaginal ultrasonography, accurately reflect the antral follicle …

Anti-Müllerian hormone (AMH), known for its role during sexual differentiation, is a dimeric
glycoprotein that belongs to the transforming growth factor-β (TGF-β) family. AMH has …

Background Anti-Müllerian hormone (AMH) is currently used as an ovarian reserve marker
for individualized fertility counseling, but very little is known of individual AMH decline in …

Quantitative decline in ovarian reserve may not be necessarily accompanied by a qualitative
decline. Although a decreased number of follicles and poor response to ovarian stimulation …

Objective: The objective of the study was to evaluate whether anti-Müllerian hormone (AMH)
is associated with fecundability among women with proven fecundity and a history of …

A diagnosis of unexplained infertility is commonly made when clinical investigations fail to
identify any obvious barriers to conception. As a consequence, unexplained infertility …

Aim Women of reproductive age with breast cancer generally receive gonadotoxic
chemotherapy. Fertility issues are of great concern for them. However, little is known on …